Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | BYON4228 |
| Synonyms | |
| Therapy Description |
BYON4228 is a monoclonal antibody that targets SIRPA, including polymorphic variants of SIRPA, and prevents its interaction with CD47, which potentially enhances macrophage and neutrophil-dependent tumor cell killing (PMID: 37068796). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| BYON4228 | BYON-4228|BYON 4228 | SIRPA Antibody 7 | BYON4228 is a monoclonal antibody that targets SIRPA, including polymorphic variants of SIRPA, and prevents its interaction with CD47, which potentially enhances macrophage and neutrophil-dependent tumor cell killing (PMID: 37068796). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|